Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
NAVB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
PFEPfizer Inc. -0.04%53.950.9%$1407.48m
JNJJohnson & Johnson -0.19%179.200.7%$1293.99m
BMYBristol-Myers Squibb Co. 0.27%77.801.0%$1215.44m
MRKMerck & Co., Inc. -0.02%92.300.7%$1166.77m
ABBVAbbVie, Inc. -0.26%150.171.9%$1097.45m
LLYEli Lilly & Co. -0.15%313.001.1%$965.80m
BHVNBiohaven Pharmaceutical Holding Co. Ltd. -0.14%142.980.0%$491.89m
AZNAstraZeneca Plc -0.05%66.671.0%$491.28m
NVSNovartis AG 0.07%91.320.2%$260.02m
GSKGlaxoSmithKline Plc 0.01%44.420.2%$257.59m
VERUVeru, Inc. 0.47%12.700.0%$254.91m
HZNPHorizon Therapeutics Plc 0.00%90.595.4%$196.03m
SGENSeagen Inc. 0.46%139.105.7%$186.52m
NVONovo Nordisk A/S -0.64%105.940.1%$181.73m
VTRSViatris, Inc. 0.58%12.080.0%$166.23m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.